44 research outputs found
ROLE OF DOPAMINE D2 RECEPTORS IN THE NEURAL CIRCUITRY UNDERLYING SEASONAL REPRODUCTION IN THE SHEEP
Seasonal reproduction in sheep is determined by changes in the responsiveness of GnRH neurons to the negative feedback action of estradiol, mediated by dopaminergic afferents and dopamine D2 receptors (D2R). It is not known whether this influence acts directly onto GnRH neurons or indirectly via interneurons such as KNDy cells. In anestrous ewes, immunocytochemistry revealed D2R expression in ~50% of GnRH neurons independent of region. In contrast, using dynorphin as a marker, D2R colocalized \u3e80% of KNDy cells and \u3c10% of dynorphin cells of the POA. No seasonal variation was found in D2R expression in GnRH cells; however colocalization significantly increased in KNDY cells ¡h anestrous vs. breeding season. Immunochemistry found that kisspeptin fibres contact GnRH neurons synaptically. Results suggest that seasonal changes in this circuit are mediated by dopaminergic afferents contacting D2R-containing KNDy neurons, which in turn decreases expression of the stimulatory neuropeptide kisspeptin, inhibiting GnRH in seasonal anestrous
Geology of the Northwestern Krania Basin
The Greveniotiki Pindos Mountains of Greece showcases the tectonics
affecting the Central Mediterranean; however no detailed geological
maps have been produced of the region. In this study we present a
1:10000 geological map of Mount Orliakas and its surrounding areas,
including westernmost parts of the Pindos Ophiolite complex and the
Mesohellenic basin. We also provide new lithological, structural, and
palaeontological discussions of the region and give new evidence for
the provenance of the Kranea Formation
Evidence that dopamine acts via Kisspeptin to Hold GnRH pulse frequency in check in Anestrous Ewes
Recent work has implicated stimulatory kisspeptin neurons in the arcuate nucleus (ARC) as important
for seasonal changes in reproductive function in sheep, but earlier studies support a role for
inhibitory A15 dopaminergic (DA) neurons in the suppression of GnRH (and LH) pulse frequency
in the nonbreeding (anestrous) season. Because A15 neurons project to the ARC, we performed
three experiments to test the hypothesis that A15 neurons act via ARC kisspeptin neurons to inhibit
LH in anestrus: 1) we used dual immunocytochemistry to determine whether these ARC neurons
contain D2 dopamine receptor (D2-R), the receptor responsible for inhibition of LH in anestrus; 2)
wetested the ability of local administration of sulpiride, a D2-R antagonist, into theARCto increase
LH secretion in anestrus; and 3) we determined whether an antagonist to the kisspeptin receptor
could block the increase in LH secretion induced by sulpiride in anestrus. In experiment 1, 40% of
this ARC neuronal subpopulation contained D2-R in breeding season ewes, but this increased to
approximately 80% in anestrus. In experiment 2, local microinjection of the two highest doses (10
and 50 nmol) of sulpiride into the ARC significantly increased LH pulse frequency to levels 3 times
that seen with vehicle injections. Finally, intracerebroventricular infusion of a kisspeptin receptor
antagonist completely blocked the increase in LH pulse frequency induced by systemic administration
of sulpiride to anestrous ewes. These results support the hypothesis that DA acts to inhibit
GnRH (and LH) secretion in anestrus by suppressing the activity of ARC kisspeptin neurons.We thank Heather Bungard and Jennifer Lydon (West Virginia
University Food Animal Research Facility) for the care of animals
and Paul Harton for his technical assistance in sectioning
tissue. We also thank Dr. Al Parlow and the National Hormone
and Peptide Program (Torrance, CA) for the reagents used to
measure LH and prolactin.http://endo.endojournals.org/am201
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19:phase 3 randomised controlled trial (CORONAVIT)
OBJECTIVE: To determine the effect of population level implementation of a test-and-treat approach to correction of suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) <75 nmol/L) on risk of all cause acute respiratory tract infection and covid 19. DESIGN: Phase 3 open label randomised controlled trial. SETTING: United Kingdom. PARTICIPANTS: 6200 people aged ≥16 years who were not taking vitamin D supplements at baseline. INTERVENTIONS: Offer of a postal finger prick test of blood 25(OH)D concentration with provision of a six month supply of lower dose vitamin D (800 IU/day, n=1550) or higher dose vitamin D (3200 IU/day, n=1550) to those with blood 25(OH)D concentration <75 nmol/L, compared with no offer of testing or supplementation (n=3100). Follow-up was for six months. MAIN OUTCOME MEASURES: The primary outcome was the proportion of participants with at least one swab test or doctor confirmed acute respiratory tract infection of any cause. A secondary outcome was the proportion of participants with swab test confirmed covid-19. Logistic regression was used to calculate odds ratios and associated 95% confidence intervals. The primary analysis was conducted by intention to treat. RESULTS: Of 3100 participants offered a vitamin D test, 2958 (95.4%) accepted and 2674 (86.3%) had 25(OH)D concentrations <75 nmol/L and received vitamin D supplements (n=1328 lower dose, n=1346 higher dose). Compared with 136/2949 (4.6%) participants in the no offer group, at least one acute respiratory tract infection of any cause occurred in 87/1515 (5.7%) in the lower dose group (odds ratio 1.26, 95% confidence interval 0.96 to 1.66) and 76/1515 (5.0%) in the higher dose group (1.09, 0.82 to 1.46). Compared with 78/2949 (2.6%) participants in the no offer group, 55/1515 (3.6%) developed covid-19 in the lower dose group (1.39, 0.98 to 1.97) and 45/1515 (3.0%) in the higher dose group (1.13, 0.78 to 1.63). CONCLUSIONS: Among people aged 16 years and older with a high baseline prevalence of suboptimal vitamin D status, implementation of a population level test-and-treat approach to vitamin D supplementation was not associated with a reduction in risk of all cause acute respiratory tract infection or covid-19. TRIAL REGISTRATION: ClinicalTrials.gov NCT04579640
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.
Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined<5 × 10(-8)) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]
Recommended from our members
Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study
Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat